Punicalagin, an active pomegranate component, is a new inhibitor of pdia3 reductase activity
Background: Polyphenolic compounds isolated from pomegranate fruit possess several pharmacological
activities including anti-inflammatory, hepatoprotective, antigenotoxic and anticoagulant activities. The
present work focuses the attention on PDIA3 interaction with punicalagin and ellagic acid, the most
predominant components of pomegranate extracts. PDIA3, a member of the protein disulfide isomerase
family involved in several cellular functions, is associated with different human diseases and it has the
potential to be a pharmacological target.